RT Book, Section
A1 Trevor, Anthony J.
A1 Katzung, Bertram G.
A1 Kruidering-Hall, Marieke M.
A1 Masters, Susan B.
SR Print(0)
ID 56985336
T1 Chapter 59. Drugs Used in Gastrointestinal Disorders
T2 Katzung & Trevor's Pharmacology: Examination & Board Review, 10e
YR 2013
FD 2013
PB The McGraw-Hill Companies
PP New York, NY
SN 978-0-07-178923-3
LK accesspharmacy.mhmedical.com/content.aspx?aid=56985336
RD 2024/04/20
AB Table  Graphic  Jump  Location|Download  (.pdf)|PrintAcid-peptic  diseaseA  group  of  disorders  involving  erosion  or  ulceration  of  the  mucosal  lining  of  the  gastrointestinal  tract;  includes  GERD,  gastric  and  duodenal  ulcers,  nonulcer  dyspepsia,  and  stress-related  gastritisAntiemeticA  drug  that  reduces  nausea  and  vomitingGastroesophageal  reflux  disease  (GERD)Esophageal  irritation  or  inflammation  due  to  reflux  of  stomach  acid;  also  known  as  heartburnGastroparesisParalysis  of  the  muscles  of  the  stomach  and  possibly  other  parts  of  the  gastrointestinal  tract  due  to  damage  to  gastrointestinal  nerves  or  muscle;  common  in  advanced  diabetes  and  advanced  Parkinson  diseaseInflammatory  bowel  disease  (IBD)Inflammatory  disorder  involving  irritation  and  ulceration  of  the  colon  and  rectum  (ulcerative  colitis)  or  the  colon  plus  more  proximal  parts  of  the  gastrointestinal  tract  (Crohn's  disease)Irritable  bowel  syndrome  (IBS)Disease  of  unknown  origin  characterized  by  episodes  of  abdominal  discomfort  and  abnormal  bowel  function  (diarrhea,  constipation,  or  both)ProkineticA  drug  that  promotes  gastrointestinal  motilityProton  pumpThe  parietal  cell  H+/K+  ATPase  that  uses  the  energy  of  ATP  to  secrete  protons  into  the  stomach  (Figure  59–1);  final  common  target  of  drugs  that  suppress  acid  secretion